Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients.

about

Management and treatment recommendations for World Health Organization Grade III and IV gliomas.

P2860

Q41706326-5965375A-AC5A-4731-B406-26AFF53FC3B4

P2860

Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients.

Item

http://www.wikidata.org/entity/Q40879813

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Radio-chemotherapy improves su ...... gh-grade astrocytoma patients.

@en

type

Item

label

Radio-chemotherapy improves su ...... gh-grade astrocytoma patients.

@en

prefLabel

Radio-chemotherapy improves su ...... gh-grade astrocytoma patients.

@en

P1476

Radio-chemotherapy improves su ...... igh-grade astrocytoma patients

@en

P2093

Dietmar Krex

http://www.w3.org/2001/XMLSchema#string

Gabriele Schackert

http://www.w3.org/2001/XMLSchema#string

Kathrin D Geiger

http://www.w3.org/2001/XMLSchema#string

Thomas Pinzer

http://www.w3.org/2001/XMLSchema#string

Tim Lautenschläger

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection

Is there pseudoprogression in secondary glioblastomas?

Molecular diagnostic techniques for the clinical evaluation of gliomas.

P2888

s11060-015-1822-1

P304

197-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-015-1822-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Tareq A Juratli

Mechthild Krause

P577

2015-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277600392

http://www.w3.org/2001/XMLSchema#string

P6179

1052259552

http://www.w3.org/2001/XMLSchema#string

P698

26033545

http://www.w3.org/2001/XMLSchema#string

Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients.

about

P2860

P2860

Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698